GSK PLC 2018 SR
The report summarizes GSK's ESG performance for 2018, focusing on 13 new commitments across science, product availability, and modern employer focus areas. Key highlights include reaching 102.7 million people through access strategies and donating 602 million albendazole tablets. The company reported a 45% female representation on the Board and a 33% female representation at the SVP/VP level. Environmentally, GSK reduced total energy consumption to 15.2 million GJ and total Scope 1 and 2 emissions to 1,429 thousand tonnes CO2e. The report also details alignment with the UN Global Compact and provides a GRI index.
Company: GSK PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2018
Type: SR
Pages: 23
Back to company
GSK PLC
ESG Performance Summary
The report summarizes GSK's ESG performance for 2018, focusing on 13 new commitments across science, product availability, and modern employer focus areas. Key highlights include reaching 102.7 million people through access strategies and donating 602 million albendazole tablets. The company reported a 45% female representation on the Board and a 33% female representation at the SVP/VP level. Environmentally, GSK reduced total energy consumption to 15.2 million GJ and total Scope 1 and 2 emissions to 1,429 thousand tonnes CO2e. The report also details alignment with the UN Global Compact and provides a GRI index.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Published
Mar 12, 2019
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees